يعرض 1 - 10 نتائج من 104 نتيجة بحث عن '"Daniil, Stroyakovskiy"', وقت الاستعلام: 1.28s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy endocrine therapy alone in patients with HR+/HER2− early breast cancer

    المؤلفون: Dennis J. Slamon, Peter A. Fasching, Sara Hurvitz, Stephen Chia, John Crown, Miguel Martín, Carlos H. Barrios, Aditya Bardia, Seock-Ah Im, Denise A. Yardley, Michael Untch, Chiun-Sheng Huang, Daniil Stroyakovskiy, Binghe Xu, Rebecca L. Moroose, Sherene Loi, Frances Visco, Valerie Bee-Munteanu, Karen Afenjar, Rodrigo Fresco, Tetiana Taran, Arunava Chakravartty, Juan Pablo Zarate, Agnes Lteif, Gabriel N. Hortobagyi

    المصدر: Therapeutic Advances in Medical Oncology, Vol 15 (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1758-8359Test

    الوصول الحر: https://doaj.org/article/73d02bee3f9e4dc6a76bef48c3ed8ce0Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

    المؤلفون: Gerald W. Prager, Julien Taieb, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, Elena Elez, Felipe M. Cruz, Lucjan Wyrwicz, Daniil Stroyakovskiy, Zsuzsanna Pápai, Pierre-Guillaume Poureau, Gabor Liposits, Chiara Cremolini, Igor Bondarenko, Dominik P. Modest, Karim A. Benhadji, Nadia Amellal, Catherine Leger, Loïck Vidot, Josep Tabernero

    المصدر: New England Journal of Medicine. 388:1657-1667

    مصطلحات موضوعية: General Medicine

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d2ded5ef27e43c94a848c73b0135c32aTest
    https://doi.org/10.1056/nejmoa2214963Test


    أضف إلى المفضلة
  3. 3
    Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

    المؤلفون: Cristiane Bergerot, Sun Young Rha, Sumanta Pal, Piotr Koralewski, Daniil Stroyakovskiy, Boris Alekseev, Francis Parnis, Daniel Castellano, Jae Lyun Lee, Kaisa Sunela, Tudor Ciuleanu, Daniel Heng, Hilary Glen, Jinyi Wang, Lee Bennett, Janice Pan, Karen O’Hara, Javier Puente

    المساهمون: Tampere University, Clinical Medicine, Department of Oncology

    المصدر: The Oncologist. 28:59-71

    مصطلحات موضوعية: Cancer Research, Oncology, 3122 Cancers

    وصف الملف: fulltext

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf88b235225b413cb5844767f9a145cTest
    https://doi.org/10.1093/oncolo/oyac142Test


    أضف إلى المفضلة
  4. 4
    Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study

    المؤلفون: Paolo A Ascierto, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Natalia Zhukova, Jacob Schachter, Yibing Yan, Ivor Caro, Christian Hertig, Cloris Xue, Lieke Kusters, Grant A McArthur, Ralf Gutzmer

    المصدر: The Lancet Oncology. 24:33-44

    مصطلحات موضوعية: Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::42a54048ddcb781074d9022f5c3e68c4Test
    https://doi.org/10.1016/s1470-2045Test(22)00687-8


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

    المؤلفون: Ralf Gutzmer, Caroline Robert, Thomas Eigentler, Qian Zhu, Helen Gogas, Grant McArthur, Paolo Ascierto, Daniil Stroyakovskiy, Svetlana Protsenko, Rodrigo Pereira, Lev Demidov, Georgy Moiseevich Manikhas, Haocheng Li, Edward McKenna, Virginia McNally

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2051-1426Test

    الوصول الحر: https://doaj.org/article/e85259d827c149f2a0ae7f4ca214a744Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Characteristics of Patients with a Complete Response Treated with Dabrafenib plus Trametinib Combination Therapy: Findings from Pooled COMBI-d and COMBI-v 5-Year Analysis

    المؤلفون: Claus Garbe, Jacob Schachter, Michael Davies, Evgeny Levchenko, Paul Burgess, Igor Bondarenko, Keith T. Flaherty, Eduard Gasal, Paul Nathan, Caroline Robert, Vanna Chiarion Sileni, Georgina V. Long, Axel Hauschild, Monique Tan, Boguslawa Karaszewska, Dirk Schadendorf, Jean J. Grob, Antoni Ribas, Daniil Stroyakovskiy

    مصطلحات موضوعية: Microbiology

    العلاقة: url:https://www.openaccessrepository.it/communities/itmirrorTest; https://www.openaccessrepository.it/record/118803Test

    الإتاحة: https://doi.org/10.25251/skin.4.supp.112Test
    https://www.openaccessrepository.it/record/118803Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

    المؤلفون: Naoyuki Nogami, Mark A. Socinski, Delvys Rodriguez-Abreu, Federico Cappuzzo, Makoto Nishio, Daniil Stroyakovskiy, Anthony Lee, Gene Grant Finley, Geetha Shankar, Tony Mok, Christian Thomas, Robert M. Jotte, Ilze Bara, Shelley Coleman, Fabrice Barlesi, David Merritt, Denis Moro-Sibilot, Wei Yu, Francisco Orlandi, Darren Wan-Teck Lim, Martin Reck, Liza C. Villaruz, Joachim G.J.V. Aerts

    المساهمون: Pulmonary Medicine, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), German Center for Lung Research, CHU de Grenoble-Alpes, Moscow City Oncology Hospital, National Stream and Aquatic Ecology Center, Biological and Physical Resources Staff, USDA

    المصدر: Journal of Thoracic Oncology, 17(2), 309-323. International Association for the Study of Lung Cancer
    JOURNAL OF THORACIC ONCOLOGY
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (2), pp.309-323. ⟨10.1016/j.jtho.2021.09.014⟩

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Population, Antibodies, Monoclonal, Humanized, Carboplatin, chemistry.chemical_compound, Atezolizumab, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Chemotherapy, education.field_of_study, Intention-to-treat analysis, Brain Neoplasms, business.industry, Liver Neoplasms, Hazard ratio, Brain, ErbB Receptors, Liver, Paclitaxel, chemistry, Mutation, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d28ac16d7f223dfc27864765b1d672Test
    https://doi.org/10.1016/j.jtho.2021.09.014Test


    أضف إلى المفضلة
  8. 8
    IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

    المؤلفون: Anthony Lee, Francisco Orlandi, Daniil Stroyakovskiy, Gene Grant Finley, Shelley Coleman, Makoto Nishio, Mark A. Socinski, Christian Thomas, Geetha Shankar, Robert M. Jotte, Federico Cappuzzo, Denis Moro-Sibilot, Shengchun Kong, Martin Reck, Delvys Rodriguez-Abreu, Fabrice Barlesi, Mark McCleland, Naoyuki Nogami, Wei Zou

    المصدر: Journal of Thoracic Oncology. 16:1909-1924

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Chemotherapy, medicine.medical_specialty, Lung Neoplasms, Paclitaxel, Bevacizumab, business.industry, medicine.medical_treatment, First line, Antibodies, Monoclonal, Humanized, Survival Analysis, Confidence interval, Carboplatin, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Overall survival, Humans, Medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71786a00e9bbdd4666e9b6e994827910Test
    https://doi.org/10.1016/j.jtho.2021.07.009Test


    أضف إلى المفضلة
  9. 9
    Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAF

    المؤلفون: Paolo A, Ascierto, Daniil, Stroyakovskiy, Helen, Gogas, Caroline, Robert, Karl, Lewis, Svetlana, Protsenko, Rodrigo P, Pereira, Thomas, Eigentler, Piotr, Rutkowski, Lev, Demidov, Natalia, Zhukova, Jacob, Schachter, Yibing, Yan, Ivor, Caro, Christian, Hertig, Cloris, Xue, Lieke, Kusters, Grant A, McArthur, Ralf, Gutzmer

    المصدر: The Lancet. Oncology.

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::ae4af7e4efee48f474b11307fefa0adbTest
    https://pubmed.ncbi.nlm.nih.gov/36460017Test


    أضف إلى المفضلة
  10. 10
    5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

    المؤلفون: Haocheng Li, Caroline Dutriaux, James Larkin, Edward McKenna, Claus Garbe, Luis de la Cruz-Merino, Athina Voulgari, Mario Mandalà, Paolo A. Ascierto, Lev V. Demidov, Victoria Atkinson, Brigitte Dréno, Antoni Ribas, Michele Maio, Gabriella Liszkay, Surai Jones, Luc Thomas, Jessie Hao-Ru Hsu, Grant A. McArthur, Daniil Stroyakovskiy

    المصدر: Clinical Cancer Research. 27:5225-5235

    مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Tumor burden, Placebo, chemistry.chemical_compound, Piperidines, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Vemurafenib, Melanoma, Complete response, Advanced melanoma, Cobimetinib, business.industry, Safety profile, chemistry, Mutation, Azetidines, Once daily, business, Follow-Up Studies, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5433fd3a5be3f5bbd73e305a6df55027Test
    https://doi.org/10.1158/1078-0432.ccr-21-0809Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث